Whether this finding can be replicated in future studies, and what significance it holds for the broader understanding of GLP-1R agonisms effects on food preference, remains to be determined
Treatment always begins at 0.75mg for the first four weeks as a starter dose to allow the body to adjust and minimize gastrointestinal side effects
The medication does not restrict specific foods, though dietary choices significantly influence treatment outcomes
These results exceed those reported in the SCALE Kids trial, in which 46% of children aged 6 to 12 years achieved a 5% reduction in BMI and the mean BMI Z score decreased by 0.7 after 56 weeks of liraglutide treatment ( These results exceed those reported in the SCALE Kids trial, in which 46% of children aged 6 to 12 years achieved a 5% reduction in BMI and the mean BMI Z score decreased by 0.7 after 56 weeks of liraglutide treatment ( Among adolescents (12 years), the mean reduction in Z-BMI was approximately 0.3, absolute BMI decreased by about 1.25 kg/m, and body weight by 1.7 kg over six months
Monitorowanie efektywnoci Podczas terapii semaglutyd, wane s regularne badania kontrolne
